Synthesis of 100G of NCGC00413972; period of performance: june 23, 2021 - august 22, 2021

Ended Purchase Order Awarded Last action

Contract number
75N95021P00293
Awardee
Awarding agency
Obligated
$23,030

Award facts

Opportunity
  • 75N95021Q00221 Solicitation number
Contract value 100% obligated
$23,030.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
325199 All Other Basic Organic Chemical Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
West Haven, CT 06516, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synovel Laboratory LLC, a self-certified small disadvantaged business and limited liability company. The contract was for the synthesis of 100 grams of the chemical compound NCGC00413972, with a period of performance from June 23, 2021 to August 22, 2021. The contract was awarded on a firm fixed price basis with a potential value of $23,030.00. This award was a prime contract with no set-aside designation. Synovel Laboratory LLC is an integrated contract research organization that provides chemical synthesis and analysis services to support pharmaceutical research and development. The company has received multiple federal contract awards from NIH to synthesize this compound in various quantities.

Quick answers

Who was awarded contract 75N95021P00293?

75N95021P00293 was awarded to Synovel Laboratory LLC by National Institute on Drug Abuse (National Institutes of Health) on June 23, 2021.

How much is contract 75N95021P00293 worth?

The government has obligated $23,030 on 75N95021P00293.

Which agency awarded contract 75N95021P00293?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00293, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95021P00293 competed?

The extent of competition for 75N95021P00293 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award